BioNeutra Global (TSXV:BGA) Total Equity : C$-8.23 Mil (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Total Equity?

BioNeutra Global's total equity for the quarter that ended in Sep. 2024 was C$-8.23 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BioNeutra Global Total Equity Historical Data

The historical data trend for BioNeutra Global's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Total Equity Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

4.75

0.70

-1.03

-3.76

-6.19

BioNeutra Global Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Equity	Get a 7-Day Free Trial															-7.50	-6.19	-7.00	-7.80	-8.23

BioNeutra Global Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BioNeutra Global's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	15.767	-	21.961
	=	-6.19

BioNeutra Global's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2024 )	-	Total Liabilities(Q: Sep. 2024 )
	=	13.575	-	21.806
	=	-8.23

BioNeutra Global Total Equity Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNeutra Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

Executives

Douglas Alan Horner	Director, Senior Officer
Monica Barclay	Senior Officer

BioNeutra Global Headlines

No Headlines